Francesco Fabbiano
Palermo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
INO-CD22: A multicenter, real-world study of inotuzumab ozogamicin safety and effectiveness in adult patients with relapsed/refractory acute lymphoblastic leukemia.
Journal: Cancer
Published: October 22, 2024
Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic Leukemia.
Journal: The Journal of molecular diagnostics : JMD
Published: November 23, 2021
Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults.
Journal: The New England journal of medicine
Published: October 21, 2020
A multicenter total therapy strategy for de novo adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocol.
Journal: Haematologica
Published: May 29, 2020
Acute promyelocytic leukaemia long-term survivors: higher fatigue and greater overall symptom burden.
Journal: BMJ supportive & palliative care
Published: February 26, 2020
Next-generation sequencing for BCR-ABL1 kinase domain mutations in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position paper.
Journal: Cancer medicine
Published: December 19, 2019
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
Journal: The New England journal of medicine
Published: October 31, 2019
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol.
Journal: Leukemia & lymphoma
Published: July 13, 2019
Last Updated: 09/26/2026